Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2241-2246, October 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leboy, P. S.
Right arrow Articles by Piester, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leboy, P. S.
Right arrow Articles by Piester, P.

Organ-specific Differences in the Methylation of Transfer RNA in Vitro1

Phoebe S. Leboy2 and Pamela Piester

Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Tissue homogenates from tumors have been reported to differ from nonneoplastic tissue in their capacity to methylate transfer RNA (tRNA). We have compared the extent of methylation obtained with several rat organs in order to determine whether similar differences can be observed among nontumorous tissues and whether differences can be attributed to variations in tissue-specific methylating enzymes.

Enzyme preparations from rat liver and spleen show differing capacities for forming several methylated nucleosides. When assayed in the presence of optimal concentrations of polyamines, these differences are observed with both unfractionated methyl-deficient Escherichia coli tRNA and E. coli formylmethionine tRNA as substrate. Distinctions between liver and spleen are also seen when polyamines are omitted from the reaction mixture; in contrast to preparations from liver, ethylenediaminetetraacetate-treated ammonium sulfate fractions of spleen homogenates methylate tRNA in the absence of added cations. The product of this methylation is 1-methyladenosine. Differences between liver and spleen preparations disappear when the enzyme preparations are eluted from a diethylaminoethyl Sephadex column. Neither ammonium sulfate fractions nor the enzymes eluting from diethylaminoethyl Sephadex are capable of completely methylating available sites on formylmethionine tRNA under conditions designed to produce maximal extent of methylation. These results suggest that organ-specific differences observed with unpurified methyltransferases are a result of inhibitory material in the enzyme preparation.

1 Supported by National Cancer Institute Grant CA 10586.

2 Recipient of Career Development Award GM 09805.

Received 3/28/73. Accepted 6/ 8/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.